Beecham Group Ltd v Bristol Laboratories Pty Ltd [1968] HCA 1

Beecham Group Ltd v Bristol Laboratories Pty Ltd [1968] HCA 1

Given the plaintiff's substantial probability of establishing patent validity and infringement at trial, and considering the balance of convenience, an interlocutory injunction should be granted to preserve the status quo and restrain the defendant pending judgment.

Jurisdiction
Australia
Procedural Posture
Appeal / Interlocutory Injunction Pending Trial
Outcome
Appeal allowed with costs; order appealed from discharged; interlocutory injunction granted.
Legal Topics
['interlocutory Injunctions' 'patent Infringement' 'balance of Convenience']
['intellectual Property' 'patents'] ['interlocutory Injunctions' 'patent Infringement' 'balance of Convenience']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Appeal / Interlocutory Injunction Pending Trial

Legal Issues

  1. 1 ["Whether the defendant's sale of hetacillin in Australia infringes the plaintiff's patents" 'Whether an interlocutory injunction should be granted to restrain the alleged infringement' 'Determination of balance of convenience between the parties']

Ratio Decidendi

Given the plaintiff's substantial probability of establishing patent validity and infringement at trial, and considering the balance of convenience, an interlocutory injunction should be granted to preserve the status quo and restrain the defendant pending judgment.

Court Disposition

Appeal allowed with costs; order appealed from discharged; interlocutory injunction granted.

Orders

  • ["Defendant, its directors, officers, servants, and agents restrained until judgment or further order from advertising, offering for sale, selling, or supplying Versapen or hetacillin or any preparation containing the same or otherwise infringing plaintiff's patents 232,312, 238,912, and 254,284." "Plaintiff's costs...